
John Rivera, Head of Research and Development at huMannity Medtec, has spent his career at the forefront of this field. Through years of research and product development, he’s identified four guiding principles that shape his approach to neuromodulation technology. These insights—rooted in a deep understanding of neurophysiology, engineering, and patient needs—highlight the complexities of creating effective, future-ready implantable devices.
Staying at the forefront of innovation is not just a goal but a necessity for medtech companies looking to make a difference. It’s a mindset that requires everyone’s participation
To say that recruiting extremely talented people at the forefront of medical technology is critical to our success is quite the understatement.
There are Med Tech companies only interested in swinging for the fences, settling for nothing less than radical, groundbreaking innovations. There are other organizations that live on the periphery, finding value in refining existing technologies. But why can’t you do both?
Nearly forty years ago, our organization—then known as The Alfred E. Mann Foundation for Scientific Research, or AMF—was founded with a clear public mission: to research and develop innovative medical technologies in search of solutions that address unmet and undermet medical conditions.